Lunai Bioworks Inc. (RENB) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Lunai Bioworks Inc.

NASDAQ: RENB · Real-Time Price · USD
1.42
0.00 (0.00%)
At close: Jun 09, 2025, 3:59 PM

Lunai Bioworks Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Cash & Equivalents
923K 311.76K 220.57K 220.47K 312.7K 243.98K 523.47K 1.87M 2.95M 4.12M 7.97M 9.17M 11.15M 13.71M 15.38M
Short-Term Investments
710.28K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
14.15K 12.05K 81.7K 19.85K 21.74K 21.74K 21.74K 21.74K 58.59K 61.68M 65.28K 61.68M 154.9M 154.91M 154.91M
Receivables
1.09M 127.08K 1.24M 1.11M n/a 1.07M 1.06M n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
943.3K 1.27M n/a 668.93K 907.22K 1.09M 324.97K 690.92K 978.88K 1.27M 160.63K 393K n/a n/a n/a
Total Current Assets
3.67M 1.71M 1.95M 2M 1.22M 2.4M 1.91M 2.57M 3.93M 5.39M 8.13M 9.57M 11.7M 14.62M 15.46M
Property-Plant & Equipment
1.39M 1.6M 1.6M 1.75M 1.87M 1.31M 1.35M 1.42M 1.49M 1.57M 1.62M 1.74M 1.87M 1.97M 2.06M
Goodwill & Intangibles
112.66M 108.02M 118.2M 159.36M 209.16M 54.28M 54.29M 54.29M 73.25M 73.25M 73.25M 11.64M 11.64M 11.64M 11.64M
Total Long-Term Assets
114.06M 109.63M 119.88M 161.13M 211.06M 55.61M 55.66M 55.74M 74.8M 74.88M 74.94M 75.07M 168.4M 168.52M 168.61M
Total Assets
117.73M 111.34M 121.83M 163.13M 212.28M 58.02M 57.56M 58.3M 78.73M 80.27M 83.07M 84.63M 180.1M 183.14M 184.06M
Account Payables
11.73M 10.93M 11.4M 9.45M 7.99M 5.58M 5.42M 5.3M 4.47M 4.56M 4.68M 1.4M 487.02K 166.75K 547.87K
Deferred Revenue
n/a n/a n/a n/a 3.75M 783.6K n/a 723.17K 593.73K -10.42M n/a n/a n/a n/a n/a
Short-Term Debt
6.53M 5.13M 2.61M 2.45M 7.6M 6.51M 3.66M 4.81M 6M 5.6M 1.2M 1.2M 6M 4.73M n/a
Other Current Liabilities
4.32M 6.47M 3.16M 12.61M 1.04M 669.38K n/a 0.00 501.05K 0.00 35.54K 2.56M 277.71K 499.88K n/a
Total Current Liabilities
28.84M 28.61M 23.04M 30.31M 20.87M 13.76M 10.1M 11.02M 11.77M 875.41K 7.16M 6.45M 7.51M 6.2M 1.21M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.2M 4.65M 4.58M n/a 1.2M 5.85M
Other Long-Term Liabilities
n/a n/a n/a n/a 19.06M n/a n/a n/a n/a n/a n/a n/a 10.31M 9.03M 8.86M
Total Long-Term Liabilities
497.63K 674.2K 710.26K 842.39K 22.81M 664.22K 720.8K 775.59K 829.21K 2.08M 5.59M 5.56M 11.35M 11.31M 15.88M
Total Liabilities
29.34M 29.28M 23.75M 31.15M 43.68M 14.42M 10.82M 11.8M 12.6M 875.41K 12.75M 12.01M 18.86M 17.52M 17.09M
Total Debt
7.03M 6.37M 3.82M 3.79M 8.57M 7.39M 4.6M 5.59M 7.04M 7.01M 6.82M 7.02M 7.32M 7.32M 7.31M
Book Value
88.39M 82.06M 98.09M 131.98M 168.6M 43.6M 46.75M 46.5M 66.13M 79.4M 70.32M 72.62M 161.24M 165.62M 166.97M
Book Value Per Share
0.54 0.51 0.63 1.37 1.57 0.66 0.72 0.73 1.18 1.43 1.28 1.37 3.06 3.17 3.20
Common Stock
16.24K 16.22K 15.76K 15.5K 14.75K 6.72K 6.57K 6.37K 5.8K 5.57K 5.55K 5.3K 5.28K 5.26K 5.22K
Retained Earnings
-383.73M -383.92M -368.89M -324.68M -274.76M -257.73M -253.2M -244.03M -220.83M -216.5M -212.04M -204.35M -114.11M -107.91M -101.32M
Comprehensive Income
775.61K -3.85M 6.3M -170.85K 1.03M -27.23K -64.48K -29.88K -32.38K -30.27K -38.19K -30.44K -21.49K -18.82K -14.83K
Shareholders Equity
88.39M 82.06M 98.09M 131.98M 168.6M 43.6M 46.75M 46.5M 66.13M 66.9M 70.32M 72.62M 161.24M 165.62M 166.97M
Total Investments
710.28K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a